EXMceuticals Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXM.CN research report →
Companyexmceuticals.com
EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries.
- CEO
- Julie Lemieux
- IPO
- 2010
- HQ
- Calgary, AB, CA
Price Chart
Valuation
- Market Cap
- $15.15M
- P/E
- -0.81
- P/S
- 0.00
- P/B
- 15.03
- EV/EBITDA
- -1.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1862.56%
- ROIC
- -967.88%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-9,806,187 · -0.49%
- EPS
- $-0.25 · 0.00%
- Op Income
- $-7,857,666
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.20
- 50D MA
- $0.20
- 200D MA
- $0.20
- Beta
- 0.85
- Avg Volume
- 0
Get TickerSpark's AI analysis on EXM.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EXM.CN Coverage
We haven't published any research on EXM.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EXM.CN Report →